Psychologic Impact of Rheumatoid Arthritis on Men

Save

Arthritis Care & Research has reported the results of a study that analyzed the perceptions and attitudes of men afflicted with rheumatoid arthritis (RA).  The results are drawn from a series of focus groups involving 22 men with RA.

Ophthalmic Giant Cell Arteritis and the Risk of Stroke

Save

Chronic inflammation is a well-known risk factor for cardiovascular disease and stroke.

Obesity Associated with Late-Onset Psoriatic Arthritis

Save

A recent study reports that obesity is linked to late-onset psoriasis and psoriatic arthritis (PsA).  By contrast being of normal weight may be associated with an earlier onset of the disease adn HLA-B27.

EULAR Recommendations on Reproductive Issues in Lupus and Anti-Phospholipid Syndrome

Save

There is a significant unmet need with regard to counseling and managing SLE and APS patients who become pregnant or who may be planning for pregnancy.

Can Marijuana Reduce Opioid Dependance?

Save

The Washington Post has reported on the variable laws, views and use of marijuana in treating pain.

Currently 1.4 million patients in 28 states use legal medical marijuana for a variety of medical conditions - chronic pain being one.

The RheumNow Week in Review – 24 February 2017

Save

Dr. Jack Cush reviews highlights from the past week on RheumNow.com:

Higher Hip and Knee Replacement Revision Rates in Younger Patients

Save

Joint arthroplasty has grown into a billion dollar industry worldwide. However, optimal timing and the success of total joint replacements in younger patient groups has not been well studied.

Quarter of Patients Claim Diet Influences Their Rheumatoid Arthritis

Save

Patients often characterize certain foods as  “inflammatory” or “anti-inflammatory” as they combat their arthritis.

Drugs Contribute to Infectious Risks in Lupus

Save

Multiple patient- and disease-related factors -- including medication use -- were associated with the development of severe infections among patients with systemic lupus erythematosus, a Spanish study found.

Abatacept Efficacy Giant Cell Arteritis

Save

This appears to be the year for biologic treatments in giant cell artertis (GCA).

Biosimilar Reports – February 2017

Save

Biosimilar reports is an ongoing series dedicated to advances, discussions and developments in biosimilar agents intended for use by rheumatologists. Many of these items were compiled from news sources, journal articles and regulatory documents and are cited and linked within each section.

The RheumNow Week in Review – 17 February 2017

Save

Dr. Jack Cush reviews this week's news and information from the 2017 RWCS meeting in Maui.

Top Ten Things Rheumatologists Should Know When Ordering Imaging

Save

As a musculoskeletal radiologist, I work every day with rheumatologists. I have been in practice for approximately 17 years and had a musculoskeletal radiology fellowship prior to establishing my practice.

Baricitinib Approved in the EU for Use in Rheumatoid Arthritis

Save

The European Commission has approved Eli Lilly's rheumatoid arthritis drug Olumiant (baricitinib) for use in Europe for RA patients with moderate-to-severe active disease in adults who have not responded one or more disease-modifying antirheumatic drugs.

Crohn's Arthritis Linked to E. Coli Infection

Save

Articular manifestations of Crohn's disease affects a significant number of patients with either oligoarticular or RA-like polyarthritis or spondyloarthritis.

Immunosuppressives Fail to Benefit Early Skin Scleroderma

Save

Treatment of systemic sclerosis is difficult, as there have few proven therapies capable of altering the course of the disease. Ideally, early intervention affords the optimal scenario wherein drug intervention can be proven to work.

ACP Recommends a Drug-Free Approach to Back Pain

Save

The American College of Physicians (ACP) recommends that physicians avoid prescribing drugs, especially narcotics, for patients with acute or subacute low back pain.

An Integrated Analysis of Tofacitinib Safety

Save

Since its US approval in 2012, tofacitinib has become a widely used treatment for rheumatoid arthritis (RA).

Whether you're impressed with its efficacy, or distressed with its side effects, its track record is voluminous and has been recently reviewed.

The RheumNow Week in Review – 10 February 2017

Save

Dr. Jack Cush discusses the news and reports from this week on RheumNow: